Recent advances in small animal imaging and the development of more accurate mouse models of human cancer provide exciting opportunities to improve radiation therapy for patients with lung cancer. The goal of this project is to elucidate molecular mechanisms of lung tumor biology following radiation therapy. Lung adenocarcinomas in mice will be imaged with X-ray computed tomography (CT) and magnetic resonance imaging (MRI) to dissect the cellular and genetic requirements for tumor response to radiation therapy. Cre-lox technology will be used to generate lung cancers with specific gene mutations. In addition, lung tumors will be produced with cell death pathways that are disrupted in tumor cells or in tumor stroma. The response of the tumors to radiation therapy will be compared by CT. These studies will clarify the role of the tumor suppressor gene p53 in the response of lung cancers to radiation therapy, determine whether apoptosis of tumor cells is required for radiation therapy to eradicate lung cancers, and identify the cellular target for radiation therapy. The vascular volume fraction of tumors will be measured with MRI and will be correlated to tumor response after irradiation. In addition, luciferase reporters that are activated during apoptosis will be optimized in cells grown in tissue culture. These reporters will be used to generate transgenic mice to develop a mouse model for in vivo bioluminescence imaging (BLI) of apoptosis. Imaging lung cancer in mice with CT, MRI, and BLI will reveal key mechanisms of how lung cancer responds to radiation therapy. The picture created from these imaging studies will ultimately form the foundation for improved treatment of patients with lung cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
7K08CA114176-03
Application #
7269833
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lohrey, Nancy
Project Start
2005-08-03
Project End
2010-07-31
Budget Start
2007-09-21
Budget End
2008-07-31
Support Year
3
Fiscal Year
2007
Total Cost
$130,329
Indirect Cost
Name
Duke University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Subashi, Ergys; Moding, Everett J; Cofer, Gary P et al. (2013) A comparison of radial keyhole strategies for high spatial and temporal resolution 4D contrast-enhanced MRI in small animal tumor models. Med Phys 40:022304
Perez, Bradford A; Ghafoori, A Paiman; Lee, Chang-Lung et al. (2013) Assessing the radiation response of lung cancer with different gene mutations using genetically engineered mice. Front Oncol 3:72
Guo, Xiaolian; Johnston, Samuel M; Qi, Yi et al. (2012) 4D micro-CT using fast prospective gating. Phys Med Biol 57:257-71
Clark, D; Johnson, G A; Badea, C T (2012) Denoising of 4D Cardiac Micro-CT Data Using Median-Centric Bilateral Filtration. Proc SPIE Int Soc Opt Eng 8314:
Badea, Cristian T; Athreya, Khannan K; Espinosa, Gabriela et al. (2012) Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent. PLoS One 7:e34496
Badea, Cristian T; Johnston, Samuel M; Qi, Yi et al. (2011) 4D micro-CT for cardiac and perfusion applications with view under sampling. Phys Med Biol 56:3351-69
Weidhaas, Joanne B; Kirsch, David G (2011) The Holman Research Pathway in radiation oncology. Int J Radiat Oncol Biol Phys 80:321-3
Kirsch, David G (2011) Using genetically engineered mice for radiation research. Radiat Res 176:275-9
Kirsch, David G; Grimm, Jan; Guimaraes, Alexander R et al. (2010) Imaging primary lung cancers in mice to study radiation biology. Int J Radiat Oncol Biol Phys 76:973-7
Johnston, S M; Perez, B A; Kirsch, D G et al. (2010) Phase-selective image reconstruction of the lungs in small animals using Micro-CT. Proc SPIE Int Soc Opt Eng 7622:76223G.1-76223G.9

Showing the most recent 10 out of 14 publications